Gastrotech signs licensing agreement with Eli Lilly and Company for compound to treat Irritable Bowel Syndrome
Gastrotech Pharma, a biopharmaceutical R&D company with a focus on the medical applications of gastrointestinal hormones, has signed an agreement with Eli Lilly and Company.
